MARTHA PEREIRA: Open Payments
NPI 1699951707 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$450 in 18 payments from 7 companies in 2025. Trend: 2023 $1,129 · 2024 $37 · 2025 $450
Food & beverage: $450
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 10 | $255 |
| Eisai Inc. | 3 | $68 |
| AstraZeneca Pharmaceuticals LP | 1 | $33 |
| Merck Sharp & Dohme LLC | 1 | $29 |
| SpringWorks Therapeutics, Inc. | 1 | $22 |
| Exeltis, USA Inc. | 1 | $21 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $20 |
Products named: JEMPERLI, Lenvima, LYNPARZA, KEYTRUDA, SLYND, JOURNAVX.
Industry payments across FL — which companies pay providers there.
